Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ankyrin repeat domain-containing protein 36B (ANKRD36B) is a human protein encoded by the ANKRD36B gene. It belongs to the family of ankyrin repeat domain-containing proteins, which are primarily involved in mediating protein-protein interactions in a wide variety of cellular processes. ANKRD36B contains multiple ankyrin repeat domains, but its specific molecular function is not well-characterized. Available evidence suggests it may be involved in cancer-related processes, with differential expression noted in tissues such as ocular melanoma and possible associations with giant axonal neuropathy. However, there are currently no established roles as a classic therapeutic target (such as being a receptor, ion channel, or enzyme), no reported small-molecule or biologic drugs targeting ANKRD36B, nor recognized use as a biomarker or therapeutic safety concern[1][4][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ankyrin repeat domain-containing protein 36B (ANKRD36B).